Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

CorMedix (CRMD) Return on Capital Employed (2016 - 2025)

CorMedix's Return on Capital Employed history spans 12 years, with the latest figure at 0.24% for Q4 2025.

  • For Q4 2025, Return on Capital Employed rose 59.0% year-over-year to 0.24%; the TTM value through Dec 2025 reached 0.24%, up 59.0%, while the annual FY2025 figure was 0.5%, N/A changed from the prior year.
  • Return on Capital Employed for Q4 2025 was 0.24% at CorMedix, down from 0.28% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.29% in Q2 2025 and bottomed at 1.05% in Q2 2024.
  • The 5-year median for Return on Capital Employed is 0.47% (2022), against an average of 0.41%.
  • The largest annual shift saw Return on Capital Employed dropped -30bps in 2024 before it skyrocketed 134bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.44% in 2021, then dropped by -25bps to 0.55% in 2022, then decreased by -14bps to 0.63% in 2023, then soared by 45bps to 0.35% in 2024, then surged by 170bps to 0.24% in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Return on Capital Employed are 0.24% (Q4 2025), 0.28% (Q3 2025), and 0.29% (Q2 2025).